NHS approves 'game changing' lung cancer drug mobocertinib - Daily Mail

A new drug targeting a rare kind of lung cancer could give patients two extra years of life after NHS drug watchdogs approving it for use. About 100 patients in England will benefit per year.

NHS drug watchdogs have today approved a 'game changing' drug for lung cancer patients. Mobocertinib tablets will be given to patients battling a rare and aggressive form of the disease, Britain's b… [+5262 chars]

full article...